Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.
about
New agents for the treatment of hepatitis C in patients co-infected with HIVHepatitis C Virus Treatment Access Among Human Immunodeficiency Virus and Hepatitis C Virus (HCV)-Coinfected People Who Inject Drugs in Guangzhou, China: Implications for HCV Treatment Expansion.Cyclooxygenase‐2 facilitates dengue virus replication and serves as a potential target for developing antiviral agentsLow Prevalence of Hepatitis C Virus Infection Among HIV-Positive Patients: Data From a Large-Scale Cohort Study in Istanbul, Turkey.Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa.Cellular activation and intracellular HCV load in peripheral blood monocytes isolated from HCV monoinfected and HIV-HCV coinfected patientsTemporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA.CD127 expression, exhaustion status and antigen specific proliferation predict sustained virologic response to IFN in HCV/HIV co-infected individuals.Hepatic safety and tolerability of raltegravir among HIV patients coinfected with hepatitis B and/or CHepatitis C Virus (HCV) NS3 sequence diversity and antiviral resistance-associated variant frequency in HCV/HIV coinfectionSustained virological response and baseline predictors in HIV-HCV coinfected patients retreated with pegylated interferon and ribavirin after failing a previous interferon-based therapy: systematic review and meta-analysis.FTO rs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients.HIV-1, HCV and alcohol in the CNS: potential interactions and effects on neuroinflammation.HIV Infection Status as a Predictor of Hepatitis C Virus RNA Testing in Primary CareCurrent management of hepatitis C virus infection in patients with HIV co-infectionCD4+ T-cell recovery with suppressive ART-induced rapid sequence evolution in hepatitis C virus envelope but not NS3.Plasma and intracellular ribavirin concentrations are not significantly altered by abacavir in hepatitis C virus-infected patients.Management algorithm for genotype 1 hepatitis C virus.Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patientsHuman hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice.Grazoprevir/elbasvir combination therapy for HCV infection.HCV therapy in HIV-infected patients.Update on HIV/HCV coinfection.Treatment of genotype 2 and genotype 3 hepatitis C virus (HCV) infection in human immunodeficiency virus positive patients.Hepatitis C virus infection in patients with HIV-1: epidemiology, natural history and management.Hepatitis C prevalence in HIV-infected individuals: a comparison of inpatient and outpatient care.Safely treating hepatitis C in patients with HIV or hepatitis B virus coinfection.[HIV infection : chronic disease with comorbidities].Direct-acting antiviral drugs for the treatment of chronic hepatitis C virus infection: Interferon free is now.In Vitro Antiviral Activity and Resistance Profile Characterization of the Hepatitis C Virus NS5A Inhibitor LedipasvirHepatitis C Virus, Inflammation, and Cellular Aging: Turning Back Time.New hepatitis C therapies for special patient populations.Management of patients who are not candidates for protease inhibitor therapyHigh HCV treatment uptake in the Swedish HIV/HCV co-infected cohort.Response-guided therapy for hepatitis C genotype 2 and 3 in those with HIV coinfection.European mitochondrial haplogroups are not associated with hepatitis C virus (HCV) treatment response in HIV/HCV-coinfected patients.HCV enters the twenty-first century.Inhibition of HCV by the serpin antithrombin IIIHepatitis in AIDS patients.
P2860
Q27006027-B8E1BCDF-60F1-4077-A507-B700F032EADFQ27321791-0EC23AAB-9578-48D2-8CAE-5FFC098FF924Q28974151-CDF00617-DB87-40D5-96C4-0584558260EEQ30863632-3BFA60C1-4836-4301-B1E3-0445DD1A56EBQ33559298-ACAD2753-3C93-465D-B033-8E41E6E88CD9Q33584149-2655E460-D93D-49BB-AFB1-2B623F8FE0A3Q33648600-46BEDDB8-F48A-463F-BD16-9EC81608866BQ33874737-82B2074E-3F60-480A-B02C-126A86BE92B6Q33940800-784558A8-0E30-4806-BD2D-3242405685F6Q34298877-B98EB3E1-E284-4E85-9B71-D74CD52F7FD2Q34362476-7BCCB892-CD94-4028-908C-BFEC9478368AQ34474404-AE1AB6A6-ED50-44AE-8F43-5F36111B0A05Q35596364-76E5AA33-A540-4B11-9BEE-DD2A19C42DB4Q36015496-299AD5C9-ED98-453C-9E23-079B268E4BE0Q36590774-B5B0F7D3-0130-4DA8-B3C9-EEA3BBB4F344Q36619647-1584674A-A65E-4CBB-96A2-C9B91D37B7C9Q36901498-8222B1E5-5DAD-46E6-82F3-A6ACFFF958AAQ36984871-E1EFC9D7-0D88-474E-9AE7-BCF55F45D2E5Q37230823-DD340959-FD0A-4165-8A61-472C26DB94C8Q37415420-94417629-DBCC-4BAF-B374-5B1B482220A7Q37671965-6E8A34D9-37BF-4BD6-BE9B-29B2981FF228Q38071389-F9B2F052-2398-41EB-B854-C713BBED2AC3Q38119893-DB8CD6F0-D163-4D9C-9C12-0B486ED312DEQ38164262-73DB1C2B-3F29-48CA-8DC5-436702943A2BQ38180719-8FBE59B4-A838-4992-B575-538B23987CA5Q38184912-08CFF71D-8AA9-4BBB-AAC8-C8D81517B77CQ38392453-1CFDD7C5-1B4C-4411-8684-63C0A54018A6Q38413754-F4382B4B-0AD8-4993-85F2-B62B0FDDF48EQ38548066-0354C622-333F-4824-81E1-68FD8E3A8C15Q38740523-33BD1653-A918-42EC-AC23-18A04CA32789Q39237702-DD346CA2-D9DC-4DCD-8592-4CE582CFB68EQ40899794-499E0F7B-156C-443D-AD98-3A45AB1D248FQ42114137-FE7C5DAF-E843-4DD7-82FD-DE47DB9ABBCCQ42207980-60410EBF-B350-4312-9B55-49DBBBEE823AQ42217488-3EBAD9CC-33E7-4D8E-BEF4-7C020EBDE32AQ42234661-B5380CB0-308B-43E8-91E5-2DAF3BDFFEB4Q42281701-2F229583-1CCE-4041-ACF2-798751534F1BQ42406960-4CB8C896-BF0A-4B7D-B0E3-0210AC4CFD3AQ48191650-39359717-2F0B-4B63-91CA-58D89E093494
P2860
Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Management of patients coinfec ...... for direct-acting antivirals.
@ast
Management of patients coinfec ...... for direct-acting antivirals.
@en
type
label
Management of patients coinfec ...... for direct-acting antivirals.
@ast
Management of patients coinfec ...... for direct-acting antivirals.
@en
prefLabel
Management of patients coinfec ...... for direct-acting antivirals.
@ast
Management of patients coinfec ...... for direct-acting antivirals.
@en
P2860
P1433
P1476
Management of patients coinfec ...... for direct-acting antivirals.
@en
P2093
Mark S Sulkowski
Susanna Naggie
P2860
P304
1324-1334.e3
P356
10.1053/J.GASTRO.2012.02.012
P407
P577
2012-05-01T00:00:00Z